Screener
Relmada Therapeutics, Inc. RLMD Total debt
Discontinued — last reported Q2 '23
Total debt at other companies
Other financials
Where this comes from
Calculated from Relmada Therapeutics, Inc.’s reported figures.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed August 8, 2023. Open the filing →
- Filed
- Aug 8, 2023
- Fiscal quarter
- Q2 FY2023
- Calendar quarter
- Q2 2023
- Accession
- 0001213900-23-064519
FAQ
- What is Relmada Therapeutics, Inc.'s total debt?
- Relmada Therapeutics, Inc. (RLMD) reported total debt of $104.06M in Q2 2023.
- How has Relmada Therapeutics, Inc.'s total debt changed year-over-year?
- Relmada Therapeutics, Inc.'s total debt decreased by 40.4% year-over-year, from $174.69M to $104.06M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Relmada Therapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude